Ritlecitinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
Journal: American journal of clinical dermatology
Published: June 18, 2026
Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment.
Journal: The Journal of dermatological treatment
Published: May 15, 2026
Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.
Journal: The Journal of dermatological treatment
Published: April 01, 2026
Dynamics of Lipid Profile in Patients With Alopecia Areata Treated With Ritlecitinib: A Descriptive, Retrospective, Real-World Study.
Journal: Journal of cutaneous medicine and surgery
Published: March 27, 2026
Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience.
Journal: Immunological medicine
Published: March 27, 2026
Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies.
Journal: Inflammopharmacology
Published: March 25, 2026
Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.
Journal: Journal of cutaneous medicine and surgery
Published: March 12, 2026
Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA.
Journal: Dermatology and therapy
Published: March 10, 2026
A Multi-Centre Real-World Evaluation of Ritlecitinib in Severe Alopecia Areata: Early Real World Experience in a British Cohort.
Journal: Clinical and experimental dermatology
Published: March 07, 2026
Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment.
Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026
Exploring novel management options for alopecia areata.
Journal: The American journal of managed care
Published: March 04, 2026
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata.
Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026
Last Updated: 06/30/2026